Underexpression of Deleted in liver cancer 2 (DLC2) is associated with overexpression of RhoA and poor prognosis in hepatocellular carcinoma

Table 2 The correlation between immunohistochemical studies and clinicopathological parameters for 128 cases of HCC specimens.

Clinicopathological parameters	No. of patients	DLC2 expression		P value
		Positive	Negative
Sex
Male	116	30	86	0.95
Female	12	3	9
Liver cirrhosis
Present	80	20	60	0.79
Absent	48	13	35
Hepatitis virus infection
Present	107	25	82	0.15
Absent	21	8	13
Capsule formation
Present	71	18	53	0.91
Absent	57	15	42
Tumor nodule
≥ 2	82	19	63	0.36
< 2	46	14	32
Cell differentiation*
I ~ II	52	20	32	0.01**
III ~ IV	76	13	63
Vein invasion
Present	54	16	38	0.39
Absent	74	17	57
Extrahepatic metastasis
Present	28	9	19	0.38
Absent	100	24	76
Tumor size
> 5 cm	70	18	52	0.98
≤ 5 cm	58	15	43